Viracta Therapeutics, Inc.
VIRX
$0.022
$0.005533.33%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.09% | 14.07% | 5.64% | -3.78% | 5.36% |
| Total Depreciation and Amortization | 3.05% | 33.24% | 72.66% | 134.29% | 100.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.33% | -57.29% | -56.78% | -56.70% | -53.80% |
| Change in Net Operating Assets | -13.17% | -75.53% | 132.59% | 735.36% | 46.36% |
| Cash from Operations | 7.87% | -11.19% | -2.73% | -12.51% | -8.64% |
| Capital Expenditure | 100.00% | 126.84% | -206.67% | -206.67% | -115.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 665.05% | 179.75% | 159.96% | 128.12% | 110.56% |
| Cash from Investing | 684.16% | 179.57% | 159.69% | 127.84% | 110.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -79.16% | -87.54% | -80.42% | -82.86% | 40.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -138.18% | -127.88% | -127.39% | -98.06% | 2,210.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.55% | 99.54% | 91.85% | 63.38% | 87.87% |